Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
Volume 10 Issue 2
Jun.  2019
Turn off MathJax
Article Contents

QIAN Jiang, SUN Zhihua, LIU Yiqiao, XIE Pinxi, ZHANGSUN Dongting, LUO Sulan. Cytotoxicity of α-conotoxin TxID in Lung Cancer[J]. Journal of Tropical Biology, 2019, 10(2): 99-105. doi: 10.15886/j.cnki.rdswxb.2019.02.001
Citation: QIAN Jiang, SUN Zhihua, LIU Yiqiao, XIE Pinxi, ZHANGSUN Dongting, LUO Sulan. Cytotoxicity of α-conotoxin TxID in Lung Cancer[J]. Journal of Tropical Biology, 2019, 10(2): 99-105. doi: 10.15886/j.cnki.rdswxb.2019.02.001

Cytotoxicity of α-conotoxin TxID in Lung Cancer

doi: 10.15886/j.cnki.rdswxb.2019.02.001
  • Received Date: 2019-04-03
  • Rev Recd Date: 2019-04-18
  • an attempt was made to study the cytotoxicity effect of α-conotoxin TxID in DMS114 s, a small cell lung cancer cell line. An α-conotoxin TxID was synthesized by solid phase peptide synthesis and two-step oxidation and identified by mass spectrometry and HPLC. The expression of α3 and β4 nAChR subunits in DMS114 cells was detected by PCR. MTT assay was used to detect the cytotoxicity of TxID or Adriamycin(ADM) or TxID combined with ADM in the DMS114 cells. The results showed that α-conotoxin TxID was successfully synthesized, and that α3 and α4 nAChR subunits were detected in DMS114 cells. The α-conotoxin TxID dependently inhibited the proliferation of small cell lung cancer DMS114 cells and HEL normal lung cells, and had higher cytotoxicity effect at some specific concentrations on DMS114 cells than on HEL cells. In addition, combination of TxID and ADM(1∶1) potentiated the cytotoxicity in DMS114 cells. In short, this study demonstrated for the first time that α-conotoxin TxID can inhibit the proliferation of small cell lung cancer DMS114 cells, which could provide guidance for the study of novel anticancer drugs.
  • [1] CHEN W, ZHENG R, BAADE P D, et al.Cancer statistics in China, 2015 [J].CA:A Cancer Journal for Clinicians, 2016, 66 (2):115-132.
    [2] BRAY F, FERLAY J.SOERJOMATARAM I.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA:A Cancer Journal of Clinicians, 2018, 68 (6):394-424.
    [3] CHEN W, ZHENG R, ZENG H, et al.Epidemiology of lung cancer in China [J].Thorac Cancer, 2015, 6 (2):209-215.
    [4] LEE P N, FOREY B A, COOMBS K J, et al.Time trends in never smokers in the relative frequency of the different histological types of lung cancer, in particular adenocarcinoma [J].Regul Toxicol Pharmacol, 2016, 74:12-22.
    [5] TRAVIS W D.Advances in neuroendocrine lung tumors [J].Ann Oncol, 2010, 21 (Suppl 7):vii65-71.
    [6] YAN Y, SU C, HANG M, et al.Recombinant Newcastle disease virus rL-RVG enhances the apoptosis and inhibits the migration of A549 lung adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine receptors in vitro [J].Virology Journal, 2017, 14 (1):1-13.
    [7] JAHCHAN N S, DUDLEY J T, MAZUR P K, et al.A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors [J].Cancer Discov, 2013, 3 (12):1364-1377.
    [8] HECHT S S.Lung carcinogenesis by tobacco smoke [J].Int J Cancer, 2012, 131 (12):2724-2732.
    [9] AMOS C I, WU X, BrODERICK P, et al.Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 [J].Nat Genet, 2008, 40 (5):616-622.
    [10] SACCONE N L, WANG J C, BRESLAU N, et al.The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans [J].Cancer Res, 2009, 69 (17):6848-6856.
    [11] IMPROGO M R, TAPPER A R.Gardner P D.Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer [J].Biochem Pharmacol, 2011, 82 (8):1015-1021.
    [12] Improgo M R, Soll L G, Tapper A R, et al.Nicotinic acetylcholine receptors mediate lung cancer growth [J].Frontiers in Physiology, 2013, 4:1-6.
    [13] MA X, JIA Y, ZU S, et al.Alpha5 nicotinic acetylcholine receptor mediates nicotine-induced HIF-1alpha and VEGF expression in non-small cell lung cancer [J].Toxicol Appl Pharmacol, 2014, 278 (2):172-179.
    [14] WANG S, HU Y.alpha7 nicotinic acetylcholine receptors in lung cancer [J].Oncol Lett, 2018, 16 (2):1375-1382.
    [15] WEI P L, CHANG Y J, HO Y S, et al.Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor [J].Ann Surg, 2009, 249 (6):978-985.
    [16] LIEN Y C, WANG W, KUO L J, et al.Nicotine promotes cell migration through alpha7 nicotinic acetylcholine receptor in gastric cancer cells [J].Ann Surg Oncol, 2011, 18 (9):2671-2679.
    [17] SHIH Y L, LIU H C, CHEN C S, et al.Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors [J].J Agric Food Chem, 2010, 58 (1):235-241.
    [18] HUANG L C, LIN C L, QIU J Z, et al.Nicotinic acetylcholine receptor subtype alpha-9 mediates triple-negative breast cancers based on a spontaneous pulmonary metastasis mouse model [J].Front Cell Neurosci, 2017 (11):336.
    [19] SARICICEK A, ESTERLIS I, MALONEY K H, et al.Persistent beta2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder [J].Am J Psychiatry, 2012, 169 (8):851-859.
    [20] QUIK M, BORDIA T.O’LEARY K.Nicotinic receptors as CNS targets for Parkinson’s disease [J].Biochem Pharmacol, 2007, 74 (8):1224-1234.
    [21] HONE A J, MEYER E L, MCINTYRE M, et al.Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the alpha6beta4* subtype [J].Faseb J, 2012, 26 (2):917-926.
    [22] SHI S, LIANG D, BAO M, et al.Gx-50 Inhibits neuroinflammation via alpha7 nAChR activation of the JAK2/STAT3 and PI3K/AKT pathways [J].J Alzheimers Dis, 2016, 50 (3):859-871.
    [23] TOKUHATA G K, LILIENFELD A M.Familial aggregation of lung cancer in humans [J].The National Cancer Institute, 1963, 30 (2):289-312.
    [24] LUO S, ZHANGSUN D, ZHU X, et al.Characterization of a novel alpha-conotoxin TxID from Conus textile that potently blocks rat alpha3beta4 nicotinic acetylcholine receptors [J].J Med Chem, 2013, 56 (23):9655-9963.
    [25] LYKHMUS O, VOYTENKO L P, LIPS K S, et al.Nicotinic acetylcholine receptor α9 and α10 subunits are expressed in the brain of mice [J].Frontiers in Cellular Neuroscience, 2017, 11 (282):1-12.
    [26] CHATTERJEE N, BIVONA T G.Polytherapy and targeted cancer drug resistance [J].Trends Cancer, 2019, 5 (3):170-182.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article views(31) PDF downloads(2) Cited by()

Proportional views
Related

Cytotoxicity of α-conotoxin TxID in Lung Cancer

doi: 10.15886/j.cnki.rdswxb.2019.02.001

Abstract: an attempt was made to study the cytotoxicity effect of α-conotoxin TxID in DMS114 s, a small cell lung cancer cell line. An α-conotoxin TxID was synthesized by solid phase peptide synthesis and two-step oxidation and identified by mass spectrometry and HPLC. The expression of α3 and β4 nAChR subunits in DMS114 cells was detected by PCR. MTT assay was used to detect the cytotoxicity of TxID or Adriamycin(ADM) or TxID combined with ADM in the DMS114 cells. The results showed that α-conotoxin TxID was successfully synthesized, and that α3 and α4 nAChR subunits were detected in DMS114 cells. The α-conotoxin TxID dependently inhibited the proliferation of small cell lung cancer DMS114 cells and HEL normal lung cells, and had higher cytotoxicity effect at some specific concentrations on DMS114 cells than on HEL cells. In addition, combination of TxID and ADM(1∶1) potentiated the cytotoxicity in DMS114 cells. In short, this study demonstrated for the first time that α-conotoxin TxID can inhibit the proliferation of small cell lung cancer DMS114 cells, which could provide guidance for the study of novel anticancer drugs.

QIAN Jiang, SUN Zhihua, LIU Yiqiao, XIE Pinxi, ZHANGSUN Dongting, LUO Sulan. Cytotoxicity of α-conotoxin TxID in Lung Cancer[J]. Journal of Tropical Biology, 2019, 10(2): 99-105. doi: 10.15886/j.cnki.rdswxb.2019.02.001
Citation: QIAN Jiang, SUN Zhihua, LIU Yiqiao, XIE Pinxi, ZHANGSUN Dongting, LUO Sulan. Cytotoxicity of α-conotoxin TxID in Lung Cancer[J]. Journal of Tropical Biology, 2019, 10(2): 99-105. doi: 10.15886/j.cnki.rdswxb.2019.02.001
Reference (26)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return